Audit and Risk Committee
The Audit and Risk Committee has John Dawson as Chair and has primary responsibility for monitoring the quality of internal controls, ensuring that the financial performance of the Company is properly measured and reported on and reviewing reports from the Company’s auditors relating to the Company’s accounting and internal controls, in all cases having due regard to the interests of Ergomed’s shareholders.
The Audit and Risk Committee is also responsible for ensuring that the Company is complying with Ergomed’s corporate governance obligations and for assessing the Company’s corporate governance practices.
The Audit and Risk Committee has four scheduled meetings each year. Dr Llew Keltner is the other member of the Audit and Risk Committee.
The Remuneration Committee reviews the performance of the executive directors and determines their terms and conditions of service, including their remuneration and the grant of options, having due regard to the interests of shareholders.
The Remuneration Committee meets at least twice a year. Mark Enyedy and John Dawson are the members of the Remuneration Committee.
The Nomination Committee has Dr. Miroslav Reljanovic as Chair and identifies and nominates for the approval of the Board, candidates to fill board vacancies as and when they arise.
The Nomination Committee meets at least twice a year.